Business Wire

TX-DENTALMONITORING

1.6.2021 12:17:11 CEST | Business Wire | Press release

Share
DentalMonitoring Continues to Disrupt the Orthodontic Market With AI-powered Solutions for Braces and Aligners of All Brands

The company that pioneered the field of virtual orthodontics and has been the market leader since 2014 is revolutionizing the industry once again with the only available AI-based virtual monitoring solution applicable to both aligner and braces treatments of all types and brands.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210601005494/en/

In an industry where a vast majority of practices are mixed users, the DentalMonitoring’s solution now allows dental professionals — whether in private practices or DSOs — to take full control of not only their aligner and but also all their braces cases. As a result DentalMonitoring expands its addressable market by close to 75%, helping more practices scale up their business, become more efficient and deliver an outstanding patient experience.

“Our solution has made yet another major breakthrough, and we are proud to unveil a new suite of functionalities of our platform,” says Philippe Salah, CEO of DentalMonitoring. “Dental professionals can now monitor all their aligner and braces cases independent of brand with the same, highly scalable AI-driven workflow. In addition to monitoring treatment progress, they can now actively define and monitor clinical goals for each patient. This results in more active control, productivity and a new level of safety and confidence for their practice: a real mindset shift for our industry.”

Salah continues: “Doctors now have complete control over all orthodontic treatment and can automatically track inter arch parameters such as the overbite, the overjet, the transverse or class correction of patients or detect the archwire and auxiliaries passivity in addition to the intra arch parameters they were already able to track with our solution. Dental professionals can virtualize and automate all non-clinical procedures and schedule appointments only when needed. At the same time, the patients’ compliance and engagement are improved, thanks to the complete revamping of our highly rated patient app.”

As the demand for remote care technology increases within the dental industry, DentalMonitoring continues to lead the way with its virtual practice solutions designed to engage, convert and monitor patients. Powered by AI and a database of over half a billion patient photographs, the virtual practice solutions are designed to give dental professionals the flexibility and convenience they need to safely address all sorts of orthodontic patient cases and optimize chair time.

About DentalMonitoring:

DentalMonitoring’s promise is to help all dental professionals improve their practice efficiency, optimize orthodontic treatment plans and enhance the patient experience thanks to its virtual practice solutions:

- SmileMate , maximizes lead engagement and patient conversion, with the ability for dental professionals to triage and qualify patients even before they step into the practice.

- DentalMonitoring , its flagship solution, monitors all treatments remotely, from aligners and braces of all brands to retention and hygiene.

DentalMonitoring operates across the United States, Europe and Asia with five offices: in Austin, TX, London, Paris, Hong Kong and Sydney.

To learn more about DentalMonitoring, visit www.dental-monitoring.com

DentalMonitoring, Smilemate and Vision are products designed and manufactured by Dental Monitoring SAS, under the DentalMind® branding for Health Care Professional.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SMBC and Toshiba Jointly Develop New Equity Indices Using Advanced Quantum-Driven Technologies28.5.2026 03:00:00 CEST | Press release

Sumitomo Mitsui Banking Corporation (“SMBC”) and Toshiba Corporation (“Toshiba”) today announced the joint development of the SMBC/TOSHIBA Quantum Driven Diversified Japan Equity Index and the SMBC/TOSHIBA Quantum Driven Diversified U.S. Equity Index, new equity indices realized with advanced quantum-driven technologies. Collectively, the indices are referred to as “SMBC/TOSHIBA Quantum Diversified” (the “Indices”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519448161/en/ Toshiba’s Simulated Bifurcation Machine 1. Background and Objectives Equity investment is central to asset management, but it also carries the ever-present risk of abrupt and substantial market fluctuations driven by geopolitical developments, changes in economic policy, and other external factors. In uncertain markets, investors are constantly seeking innovations in risk diversification that can protect their assets from unexpected market shocks. SM

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 202627.5.2026 23:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy demonstrated statistically significant overall survival benefit with an unprecedented seven-month improvement in first-line HER2+ GEAOral presentation at ASCO highlights benefit regardless of PD-L1 status, including in PD-L1 <1% BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be presented in an oral presentation (Rapid Oral Abstract: 4010) at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2026, in Chicago.The HERIZON-GEA-01 clinical trial evaluated ZIIHERA® (zanidatamab) plus chemotherapy, with and without TEVIMBRA® (tislelizumab), compared with the control arm of trastuzumab plus chemotherapy as first-line treatment for advanced/metastatic HER2+ gastroesophageal adenocarcinoma (GEA). Dr. Sun Young Rha, Professor of Medical Oncology at the Yonsei Cancer Center, Yonsei Univ

Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards27.5.2026 17:22:00 CEST | Press release

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental factors which impact allergies, is delighted to announce the recipients of the 2025 edition of its prestigious Science Awards for Allergy. Building on the success of the previous edition, this year’s awards recognise outstanding contributions to allergy research and patient engagement and allocate a total of €100,000 to support these initiatives. Four researchers have been selected by the Board as award recipients, each receiving €25,000 across two categories: Innovation In Treatment Awards Assoc. Professor Alexander Eggel, PhD, Department for Biomedical Research, University of Bern, and Department of Rheumatology and Immunology, University Hospital Bern, Switzerland, recognised for his research: “Improving diagnostic and therapeutic options for allergic patients”; Dr Janice A. Layhadi, PhD, Research Associate, National Heart and Lung Institute, Imperial College

Capchase Secures $200M+, as Demand for Vendor Financing in Enterprise Tech Deals Accelerates27.5.2026 16:00:00 CEST | Press release

As buyers face tighter budgets, Capchase helps technology companies close more deals faster with AI-enabled instant financing Capchase, the leading vendor financing platform for enterprise tech, today announced $200M+ in incremental funding to scale its embedded financing infrastructure globally and deploy more AI-enabled features. The funding, a mix of debt warehouse facilities and equity backed by institutional investors, reflects market validation that vendor financing has become essential infrastructure for enterprise technology companies to sell hardware and software products. As global B2B buyers face tighter budgets and greater scrutiny over large, up-front purchases, financing demand is growing. The Market Shift: Financing as a Growth Lever for B2B Tech Companies The $1.3 trillion vendor financing market has been traditionally dominated by banks and other lenders that utilize multi-thread email chains to manual doc review for underwriting. Capchase replaces those bottlenecks wi

ClickHouse Tops $250M ARR and 4,000 Customers, Launches Claude-Powered Agents at Open House 202627.5.2026 15:00:00 CEST | Press release

Annual run-rate revenue more than tripled year-over-year; new CostBench benchmark shows ClickHouse Cloud at 23x better cost-performance than the nearest cloud data warehouse ClickHouse today opened Open House 2026, its second annual user conference, with a set of announcements that mark one of the company's most active quarters since founding. ClickHouse’s serverless cloud offering has crossed over $250 million in annual run-rate revenue — more than triple a year ago — and added more than 1,000 net new customers since January, bringing its total to 4,000. To meet the demands of AI-era workloads, the company also launched ClickHouse Agents, a fully managed agentic analytics service powered by Anthropic's Claude; published CostBench, an open benchmark comparing the major cloud data warehouses on cost-performance; and introduced House Mates, its first formal partner program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye